| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 22.95B | 21.24B | 22.84B | 19.75B | 18.51B | 19.50B |
| Gross Profit | 9.02B | 8.65B | 9.02B | 7.67B | 6.95B | 7.29B |
| EBITDA | 4.53B | 4.26B | 4.59B | 3.48B | 2.91B | 3.14B |
| Net Income | 2.39B | 2.21B | 2.41B | 1.74B | 1.32B | 1.53B |
Balance Sheet | ||||||
| Total Assets | 20.96B | 22.51B | 23.86B | 23.79B | 22.14B | 23.13B |
| Cash, Cash Equivalents and Short-Term Investments | 5.78B | 5.14B | 5.51B | 5.02B | 3.81B | 4.72B |
| Total Debt | 3.34B | 3.26B | 3.60B | 4.02B | 4.87B | 5.85B |
| Total Liabilities | 8.96B | 8.71B | 11.49B | 13.10B | 12.99B | 14.91B |
| Stockholders Equity | 11.99B | 13.78B | 12.36B | 10.58B | 9.05B | 8.13B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 887.12M | 1.51B | 2.49B | 267.98M | -37.23M |
| Operating Cash Flow | 0.00 | 1.61B | 2.20B | 3.14B | 1.04B | 600.13M |
| Investing Cash Flow | 0.00 | -742.02M | -692.74M | -581.47M | -446.32M | -589.68M |
| Financing Cash Flow | 0.00 | -1.25B | -1.07B | -1.31B | -1.43B | -1.02B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | ¥59.65B | 7.89 | ― | 3.25% | 15.03% | 223.61% | |
72 Outperform | ¥13.38B | 5.97 | ― | 3.95% | -6.98% | -7.51% | |
71 Outperform | ¥25.69B | 12.89 | ― | 5.04% | 0.95% | -5.24% | |
68 Neutral | ¥11.92B | 26.30 | ― | 1.24% | 5.74% | 10.43% | |
66 Neutral | ¥75.12B | 6.55 | ― | 2.30% | 19.53% | 117.58% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
55 Neutral | ¥18.52B | 26.03 | ― | 3.24% | -6.49% | ― |